REBEL: A randomised phase I/II trial of lenalidomide and rituximab with or without bendamustine in patients > 18 years with relapsed follicular lymphoma

Project: Research

Project Details

StatusFinished
Effective start/end date5/01/20184/01/2021

Funding

  • HOVON Dutch-Belgian Cooperative Trial Group for Hematology-Oncology: £12,320.00